PTX-dependent ERK1/2 activation was observed in GALR2-transfected HNSCC cells; however, both PTX and U0126, an ERK-specific inhibitor, partially abrogated GALR2-induced cytotoxicity [44]. The gene discussed is MAPK3; the disease is head and neck squamous cell carcinoma.